11.2 Capital

11.2 Capital stands out in the vibrant landscape of earlystage investment firms. Hailing from San Francisco, this unique entity has carved a niche for itself, focusing intently on the deeptech frontier. The firm draws its name from Earth’s escape velocity, a fitting moniker for a firm that seeks to propel innovative companies to new heights. Specializing in areas such as artificial intelligence, cybersecurity and robotics, 11.2 Capital possesses a distinctive profile. The firm is particularly noted for its rare emphasis on bioengineering, setting it apart from many of its counterparts in the venture capital arena. This focus enables 11.2 Capital to back ventures that not only push the boundaries of technology but also possess the potential to transform entire industries. The investment approach here is rooted in deep technical expertise, making the firm a preferred partner for founders tackling intricate challenges in research and development. The partners themselves come equipped with impressive technical credentials, ensuring that they can engage meaningfully with the complexities that arise in product development. This level of involvement facilitates not just capital infusion but also strategic guidance, fostering relationships that transcend traditional investor dynamics. As 11.2 Capital navigates the investment landscape, it delivers value that goes beyond mere financial support. With investment stages ranging from preseed through Series B+, the firm positions itself as a beacon for highpotential startups at various phases of their development. This commitment to nurturing visionary teams, particularly those operating at the intersection of technology and science, promises not only substantial returns but also impactful societal advancement. In a world increasingly shaped by technological innovation, 11.2 Capital remains at the forefront, identifying and catalyzing the breakthroughs that define our future.